Phoenix Bell
Impact in
-
- Venous Thromboembolism Diagnosis and Management
-
- Appendicitis Diagnosis and Management
Papers in
- Co-authors
- Majed A. Refaai (1 shared paper)Paul Riley (1 shared paper)Reetesh K. Pai (2 shared papers)Aaron R. Huber (7 shared papers)Aatur D. Singhi (3 shared papers)Amitabh Srivastava (2 shared papers)Michael Li (1 shared paper)Shilpa Grover (1 shared paper)
- Journals
- Human Pathology (2 papers)The American Journal of Surgical Pathology (1 paper)Histopathology (1 paper)Seminars in Diagnostic Pathology (1 paper)Diagnostic Pathology (1 paper)
- Partner nations
- United StatesSaudi Arabia
In The Last Decade
Phoenix Bell
19 papers receiving 143 citations
Peers
Comparison fields: 5 of 51
- Internal Medicine 17
- Emergency Medicine 38
- Reproductive Medicine 32
- Oncology 47
- Hematology 15
Countries citing papers authored by Phoenix Bell
This map shows the geographic impact of Phoenix Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phoenix Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phoenix Bell more than expected).
Fields of papers citing papers by Phoenix Bell
This network shows the impact of papers produced by Phoenix Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phoenix Bell. The network helps show where Phoenix Bell may publish in the future.
Co-authors
The 25 scholars most cited alongside Phoenix Bell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 40 | |
| 2 | 2021 | 20 | |
| 3 | 2021 | 16 | |
| 4 | 2020 | 13 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 7 | |
| 8 | 2019 | 7 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 5 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2020 | 1 |
About Phoenix Bell
Phoenix Bell is a scholar working on Oncology, Surgery, Epidemiology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 20 papers that have together received 150 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Appendicitis Diagnosis and Management (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Internal Medicine (17 citations), Emergency Medicine (38 citations), Reproductive Medicine (32 citations), Oncology (47 citations) and Hematology (15 citations). Phoenix Bell has collaborated with scholars based in United States and Saudi Arabia. Frequent co-authors include Majed A. Refaai, Paul Riley, Reetesh K. Pai, Aaron R. Huber, Aatur D. Singhi, Amitabh Srivastava, Michael Li, Shilpa Grover, Osama E. Rahma and Raul S. González. Their work appears in journals such as Human Pathology, The American Journal of Surgical Pathology, Histopathology, Seminars in Diagnostic Pathology and Diagnostic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.